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Abstract Expression of single-chain antibody fragments (scFvs) 
in the plant cytosol is often cumbersome. It was unexpectedly 
shown that addition at the C-terminus of the ER retention signal 
KDEL resulted in significantly improved expression levels. In 
this report the cytosolic location of the scFv-CK was confirmed, 
excluding possible mistranslocation to other subcellular compart-
ments. It was shown that expression of several other scFvs was 
also improved in tobacco protoplasts. In addition expression was 
improved in transgenic potato. Changing from KDEL to KDEI 
did not affect the enhanced protein expression level. Addition of 
the KDEL motif is a simple and straightforward tool to stabilize 
in planta cytosolic expression of many scFvs. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The expression of specific antibodies or antibody fragments 
in plant cells to obtain phenotypic mutants, like resistance 
against pathogens [1,2] or altered metabolic pathways [3,4], 
has proved its potential. The use of single-chain Fv fragments 
(scFvs), consisting of the variable heavy and light chain do-
mains coupled by a linker peptide, is of particular interest 
since these molecules were functionally expressed in both the 
secretory pathway and ectopic environments. Even in the re-
ducing environment of the plant cytosol scFvs can fold into 
functional molecules. This folding capability has also been 
demonstrated in Xenopus oocytes, COS cells and human cells 
[5,6]. 
Despite these successes, cytosolic expression of scFv anti-
bodies in plants is often low or absent [7-11]. If the stability in 
*Corresponding author. Fax: (31) (317) 484254. 
E-mail: sander.schouten@medew.nema.wau.nl 
Present address: Department of Plant Pathology, Iowa State 
University, 351 Bessey Hall, Ames, IA 50011, USA. 
Abbreviations: EDTA, ethylenediaminetetraacetic acid; ER, endo-
plasmic reticulum; HEPES, N-(2-hydroxyethyl)piperazine-iV'-(2-etha-
nesulfonic acid); NP-40, nonidet P-40; PAGE, polyacrylamide gel 
electrophoresis; PCR, polymerase chain reaction; PVDF, polyvinyli-
dene difluoride; rER, rough endoplasmic reticulum; SDS, sodium 
dodecyl sulfate 
The sequences reported in this work have been deposited in the 
GenBank database (accession numbers AF004403; AF004404; 
AF004405; AF004406; AF004407). 
the cytosol is an intrinsic property of the variable domains it 
will be a tedious job to improve expression levels for each 
individual scFv antibody without losing affinity. It would 
therefore be more convenient to search for a general approach 
to stabilize cytosolic scFv molecules without modifying the 
variable domains. 
Recently, we obtained a significantly improved stability in 
tobacco when the tetrapeptide KDEL was added at the C-
terminal end of an anti-cutinase scFv (scFv-CK) designed to 
be located in the cytosol [9]. This tetrapeptide is the signal for 
retaining proteins in the endoplasmic reticulum (ER) when 
translocated into the secretory pathway [3,12-14]. The addi-
tion of a four amino acid extension may be a valuable ap-
proach to stabilize cytosolic scFvs without modifying the var-
iable domains. 
In this report we first established that scFv-CK was present 
in the cytosol of tobacco, to exclude possible mistranslocation 
to the ER, reported by [15], as a cause of improved scFv 
protein expression levels. We then investigated if the tetrapep-
tide KDEL could also be beneficial for the cytosolic expres-
sion level of several other scFv antibodies and be successfully 
applied for the expression of scFvs in another plant species, 
potato. Finally, to study whether or not the tetrapeptide could 
be slightly modified without losing its positive effect on pro-
tein stability in the cytosol, the leucine of the tetrapeptide 
KDEL of one of the scFvs was changed into isoleucine and 
this antibody fragment was expressed in potato. 
2. Materials and methods 
2.1. Cell lines, vectors and strains 
Single-chain antibodies were constructed starting from the hybrid-
oma cell lines MGR48, MGR49 and MGR59 [16], all producing 
monoclonal antibodies reacting with ß-l,4-endoglucanase, and from 
the hybridoma line anti-GUS, which produces an anti-ß-glucuroni-
dase monoclonal antibody. 
For construction of the various 21C5 anti-cutinase scFv genes the 
vectors pNEM-scFv, pNEM-scFv-K and pCPO-scFv-CK [9] were 
used. 
For transient expression assays scFv antibodies were cloned in 
pRAP-scFv-SK, pTR2-scFv-SK or pTR2-scFv-S. To obtain pRAP-
scFv-SK the vector pUCAP35S [17] was provided with a kappa signal 
peptide [18] and the scFv cassette with carboxy-terminal KDEL ex-
tensions, obtained from the vector pNEM-scFv-K [9]. The vector 
pRAP-scFv-SK thus obtained can accept other scFv encoding genes 
as Sali/Notl fragments between the kappa signal peptide and the c-
myc tag plus C-terminal KDEL extension. To obtain pTR2-scFv-SK 
and pTR2-scFv-S we first cloned the 1.4 kbp Hindlll fragment from 
pCP05 [19] containing the 35S terminator (T35S), the TR2'-1' dual 
promoter and octopine synthase terminator (Toes) into the Hindlll 
site of pAP [17]. Then the original San site, present between the TR1' 
promoter and Toes, was removed by filling in, creating the vector 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793 (9 7)01129-0 
236 A. Scheuten et al.lFEBS Letters 415 (1997) 235-241 
pTR2. The anti-cutinase scFv cassettes with the coding sequence for 
signal peptide and C-terminal c-myc tag, with and without KDEL 
retention signal, were isolated from pNEM-scFv-K and pNEM-scFv 
as NcoIIBcH fragments and inserted into Ncol/BamHI digested pTR2, 
resulting in the vectors pTR2-scFv-SK and pTR2-scFv-S, respectively. 
2.2. Construction of scFv genes with coding sequence for glycosylation 
in the linker 
To modify the 202' derived peptide linker [20] of the 21C5 anti-
cutinase scFv the VL domain was reamplified using the primers 
L5d (5'-GGTGTCGACGGTGATGTTKTGATGACCCAAA-3') and 
Vkglyc (5'-AGCCGGATCCGTTGGATTTACCCTCGAGTTTTAT-
TTCCARCTTKGTSCC-3'). Restriction sites in the primers, used in 
the cloning procedure, are underlined. PCR conditions were used as 
described by [9]. The amplified fragment was inserted into the Sail/ 
BamHI restricted vector pNEM-scFv. The resulting pNEM-scFvglyc 
contained a linker flanked by Xhol sites. With respect to the original 
scFv the Arg at position 1 of the peptide linker was replaced by Leu 
(Fig. 1). The Ser at position 6 was replaced by Asn, thereby creating a 
consensus site for N-linked glycosylation [21]. A control scFv con-
struct in which the Asn was replaced by Ser, but the Leu at position 1 
retained, was obtained by inserting an XhoIIBamHI adapter fragment 
(5'-TCGAGGGTAAATCCTCCG-3' and 5'-GATCCGGAGGATT-
TACCC-3') into XhoIIBamHI digested pNEM-scFv*«, creating 
pNEM-scFvAglyc. The modified scFv constructs were cloned as Salli 
NotI fragments from pNEM-scFvglyc and pNEM-scFvÄglyc into 
pRAP-scFv-SK, creating pRAP-scFvglyc-SK and pNEM-scFvÄglyc-SK, 
respectively (Fig. 1). 
The scFv gene insert from the vector pRAP-scFv-SK was replaced 
by the NcoIINotI scFv insert from pCPO-scFv-CK, resulting in the 
vector pRAP-scFv-CK. To obtain scFv-CK constructs with identical 
linker peptide coding sequences with and without glycosylation signal 
the PstI fragment in this vector was replaced by the same insert from 
the vectors pRAP-scFvglyc-SK and pRAP-scFvAglyc-SK. The resulting 
constructs were verified on proper orientation and subsequently called 
pRAP-scFv<*"c-CK and pRAP-scFvÄglyc-CK, respectively (Fig. 1). 
2.3. Immunocytolocalization 
Young leaves (length approximately 3 cm) of in vitro grown trans-
genic tobacco plants, expressing the anti-cutinase scFv-CK and scFv-
SK antibodies, were submersed in a solution of 4% formaldehyde, 0.1 
M HEPES-NaOH pH 7.5 and 1.5 mM CaCl2. The leaf tissue was cut 
into strips of approximately 1 x 5 mm, which were degassed briefly in 
vacuo and left to fix overnight at room temperature. Following wash-
ing in water, the leaf strips were dehydrated in ethanol and embedded 
in LR-Gold resin following standard low-temperature procedures [22]. 
Immunogold labeling of thin sections was performed essentially as 
described by [16], using monoclonal antibody 9E10 to the c-myc tag 
at a concentration of 1 μg/ml as the primary antibody, and a 10 nm 
goat anti-mouse gold conjugate (Aurion, Wageningen, The Nether-
lands) for detection. Control labeling experiments were performed 
with leaf tissue from untransformed plants, and by omitting the pri-
mary antibody in the labeling procedure. 
2.4. Construction of scFv antibody genes 
Isolation of poly(A)+ RNA from hybridoma cells was performed 
using the QuickPrep Micro mRNA purification kit (Pharmacia). 
cDNA was synthesized using the Pharmacia First Strand cDNA Kit. 
To create the scFv4g gene the MGR48 cDNA was amplified by 
PCR using the primer combination L5d-Nco (5'-CGTGCCATG-
GATGTTKTGATGACCCAAACTC-3') and 202VL3 (5'-GGATT-
CAGATCCGGATCCTGAGGACTTACCCTCGAGCTTTATTTCC-
AGCTTGGTCCC-3') for the VL domain and 202VH5 (5'-
TCAGGATCCGGATCTGAATCCAAGCTCGAGTCTCAGGTCC-
AGTTGGTACAGTCTG-3') and VH33b (5'-GCACGTTAAC-
CCCGGGTGTTGTTTTGGCTGCAGAGACAG-3') for the VH do-
main. The Ncol/BamHI digested VL and BamHI/Hpal digested VH 
fragments were ligated together in the Ncol/Smal digested pTR2-
scFv-S and pTR2-scFv-SK. 
For the SCFV49 construction we amplified MGR49 cDNA using 
primer combination L5h (5'-GGTGTCGACGGTGACATCCAGAT-
GACMCAGWCTMCM-3') and 3KGS to obtain VL and 5HGS 
(5'-GGTGGAGGATCCGGTGGAGGAGGTTCTGAGGTYCAGC-
TG-CARSA-3') and VH34 (5'-ATGCGTTAACCGTTGTTTTGG-
CTGMRGAGACDGTGAS-3') to obtain VH. The VL and VH do-
mains were fused using splicing by overlap extension (SOE) [23] and 
initially ligated as a SaWHpal fragment into pNEM6 [24]. Finally the 
scFv4s fragment was cloned as NcoIINotI fragment into NcoIINotI 
digested pTR2-scFv-S and pTR2-scFv-SK. 
To create scFvsg MGR59 cDNA was amplified with the primers 
L5d-Nco and 3Kgs2 (5'-CGCCrCCGC4GCCTCCACCACCGGAA-
CCACCACCACCGGATCCCCCTTTTATT-TCCARCTTKTGTC-
CC-3') for the VL domain and gsH5c (5'-GGTGGAGGCJCCG-
G^G-GCGGAGGATCCGAGGTCCAGCTGCAACARTC-3') and 
VH33a (5'-GCACGTTACC-CCGGGTGTTGTTTTGGCTGAGGA-
GACKG-3') for the VH domain. After NcoIIBspEI and BspEIISmal 
digestion the domains were ligated together in the NcoIISmal digested 
pTR2-scFv-S and pTR2-scFv-SK. 
To create SCFVQUS anti-GUS cDNA was amplified using the primer 
combination L5h and VLK2 (5'-GACTCGAGTTTGGATTCGGA-
GCCGGATCCTGAGGATTTACCCTCCCGTTTTATTTCCARCT-
TKGTCC-CMG-3') to obtain VL and primer combination FVH3 
(5'-TCAGGATCTGGCTCCGAATCCAAACTCGAGTCTGAGGT-
GAAGCTGGTGGARTCTG-3') and VH33 to obtain VH. The VL 
and VH domains were fused by SOE and initially ligated as a SalU 
Smal fragment into pNEM5 [9]. Then the SCFVQUS gene was ligated as 
NcoIINotI fragment into NcoIINotI digested pRAP-scFv-S and 
pRAP-scFv-SK. 
Cloning procedures were according to [25]. All constructs were 
checked by sequencing [26]. 
2.5. Transient expression and protein analysis 
Transient expression assays in tobacco (Nicotiana tabacum cv. Sam-
sun NN) leaf protoplasts were performed essentially according to the 
polyethylene glycol procedure as described by [27]. In case of tunica-
mycin treatment the transfected protoplast were incubated in TEX 
medium supplemented with 10 μg/ml tunicamycin [28]. 
The protoplasts were separated from the incubation medium and 
lysed by adding an equal volume of 10 mM Tris-HCl, pH 8.0, 1 mM 
EDTA and 1 mM Pefabloc SC (Boehringer), and subsequent vortex-
ing. The chloroplasts were pelleted by centrifugation at 13000Xg for 
2 min and the supernatant was used for further analysis. For Western 
analysis one third volume of 4 X SDS-PAGE sample buffer, containing 
244 mM Tris-HCl, pH 6.8, 8% (w/v) SDS, 50% (w/v) glycerol and 
1 mM Pefabloc SC (Boehringer), was added to an aliquot of the 
supernatant, equaling 3X 104 protoplasts. The samples were incubated 
at 100°C for 5 min and bromophenol blue was added to a final con-
centration of 0.008% (w/v). 
For deglycosylation proteins isolated from 8 X104 protoplasts in a 
final volume of 20 μΐ were denatured by adding 2.2 μΐ 5% (w/v) SDS, 
2% (v/v) ß-mercaptoethanol and incubation at 100°C for 5 min. The 
sample was split into two portions. Both aliquots received 2 μΐ 0.5 M 
sodium phosphate, pH 7.5, 3 μΐ water and 2 μΐ 10% (v/v) NP-40. To 
the first aliquot 2 μΐ PNGase F (500 units/μΐ, New England Biolabs) 
was added. As a control, 2 μΐ water was added to the second aliquot. 
The samples were incubated at 37°C for 1 h and bromophenol blue 
was added to a final concentration of 0.008% (w/v). 
Protein samples were loaded on a 13% SDS-polyacrylamide gel [29] 
(Bio-Rad mini protean system). After electrophoresis the proteins 
were transferred to a PVDF membrane (Millipore) by electroblotting. 
For immunodetection the membranes were incubated with 1:1000 
diluted 9E10 monoclonal antibody [30], followed by a 1:5000 diluted 
rat anti-mouse alkaline phosphatase conjugate (Jackson Immuno Re-
search). The blots were stained in 0.1 M ethanolamine-HCl pH 9.6, 
supplemented with 4 mM MgCi2, 5-bromo-4-chloro-3-indolyl phos-
phate (0.06 mg/ml) and nitroblue tetrazolium (0.1 mg/ml). The relative 
molecular weights of the proteins were estimated with pre-stained low 
range molecular weight markers (Bio-Rad). 
2.6. Potato transformation and protein analysis 
The scFv4s expression cassettes cloned in the transient expression 
vector pTR2 were isolated as PacI-AscI fragments and transferred to 
the binary vector pBINPLUS as described by [17]. The resulting plas-
mids were introduced into Agrobacterium tumefaciens strain AGL0 
[31]. This strain was used for the transformation of internodal stem 
sections of Solanum tuberosum, dihaploid genotype 6487-9 
(2n = 2x = 24), as described by [32]. Genotype 6487-9 resulted from a 
cross between genotype 1024-2 [33] and genotype 91-6222-40, a self-
incompatible Gg clone selected in 1992 from the material of [34]. 
Kanamycin resistant transformants were regenerated and total soluble 
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proteins were extracted by grinding roots essentially as described by 
[18]. The proteins were analyzed by loading 30 μg total soluble protein 
homogenate on an SDS-polyacrylamide gel followed by electroblot-
ting and immunodetection as described. 
3. Results 
3.1. Subcellular location of the scFv antibodies in plant cells 
To study possible 'mistranslocation' of scFv-CK to the ER 
we used N-linked glycosylation as a biochemical marker. A 
mutant, scFvglyc-CK (Fig. 1) was engineered, having a con-
sensus glycosylation site (Asn-Gly-Ser) in the linker peptide. 
Both this construct and the construct having the original Ser-
Gly-Ser peptide coding sequence in the linker (scFvAglyc-CK, 
Fig. 1) were expressed transiently in tobacco protoplasts. As 
controls we took the scFvglyc-SK and scFvAglyc-SK constructs 
which carry both the ER translocation signal sequence and an 
ER retention signal KDEL (Fig. 1). Glycosylation was deter-
mined by the relative migration of these proteins on Western 
blot (Fig. 2). ScFvglyc-SK expression resulted in proteins mi-
grating at 32, 33 and 67 kDa (Fig. 2, lane 1). The 67 kDa 
protein is thought to be an scFv dimer due to disulfide bridge 
formation caused by the cysteine present in the linker peptide 
(Fig. 1) [9]. Due to the presence of ß-mercaptoethanol in the 
reaction buffer this dimer was absent after glycosidase F treat-
ment. When the transfected protoplasts were incubated in the 
presence of the glycosylation inhibitor tunicamycin or after 
glycosidase F treatment of the total protein homogenate, the 
33 kDa band disappeared and the 67 kDa band slightly 
shifted to 65 kDa (Fig. 2, lane 2). Expression of scFvAglyc-
SK resulted in 32 and 65 kDa bands which were unaffected 
by glycosidase F treatment of the total protein homogenate or 
tunicamycin treatment of the transfected protoplasts (Fig. 2, 
lanes 3 and 4). This indicates that the 33 kDa and 67 kDa 
proteins are glycosylated forms of the 32 kDa scFv monomer 
and 65 kDa scFv dimer. The band intensities of the 33 and 32 
kDa bands indicate that approximately 70% of the scFvglyc-
SK protein became glycosylated. Because of a three amino 
acid extension at the N-terminus the apparent molecular 
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Fig. 1. Diagram of the scFv-SK and scFv-CK constructs with modi-
fications in the linker peptide. The signal for N-linked glycosylation, 
Asn-X-Ser, was introduced by changing the Ser of both scFvAglyc-
SK and scFvAglyc-CK to Asn, resulting in the sequence Asn-Gly-Ser 
in the constructs scFvglyc-SK and scFvglyc-CK, respectively. The N-
terminal signal peptide (SP), the single-chain antibody construct 
(scFv) with the variable light (VL) and heavy (VH) chain domains 
connected by the linker peptide, the C-terminal c-myc tag (tag) fol-
lowed by the KDEL peptide sequence are indicated. 
Fig. 2. Determining the glycosylation state of scFvglyc-SK and 
scFvglyc-CK proteins. Top panel: Western blot of total protein from 
tobacco protoplasts, transfected with the vectors containing the 
scFvglyc-SK, scFvAglyc-SK, scFvglyc-CK and scFvAglyc-CK gene cas-
settes, were incubated in the absence (—) or presence (+) of tunica-
mycin and analyzed on Western blot. Arrow indicates the 67/65 
kDa protein bands. Bottom panel: Western blot of total protein 
from protoplasts, transfected with the vectors containing the 
scFvglyc-SK, scFvAglyc-SK, scFvglyc-CK and scFvAglyc-CK gene cas-
settes, which had been incubated in the absence of tunicamycin and 
were either mock treated (—) or treated (+) with the endoglycosi-
dase glycoF. As a negative control (Control) a vector without scFv 
gene cassette was used. 
weight of the expressed scFvglyc-CK and scFvAglyc-CK pro-
teins is slightly higher than the scFvAglyc-SK and unglycosyl-
ated scFvglyc-SK proteins and was estimated at 33 kDa (Fig. 
2, lanes 5 and 7). For both scFvglyc-CK and scFvAglyc-CK the 
mobility was unaffected by glycosidase F treatment of the 
total protein homogenate or tunicamycin treatment of the 
transfected protoplasts (Fig. 2, lanes 6 and 8). Therefore, we 
conclude that the scFvglyc-CK protein is not glycosylated, in-
dicating that the scFv-CK antibody, in contrast to the scFv-
SK antibody, is not translocated into the ER. 
To obtain 'visual' proof of the presence of the scFv-CK 
antibodies in the cytosol, we examined leaf sections of trans-
genic plants expressing the anti-cutinase scFv-CK and scFv-
SK antibodies with immunoelectron microscopy (Fig. 3). We 
had obtained transgenic plants with maximum expression lev-
els of 0.2% and 1% of total soluble protein for scFv-CK and 
scFv-SK, respectively [9]. Leaf sections were prepared from 
transgenic plants expressing scFv-CK at a level of 0.2% and 
scFv-SK at levels of 0.2% and 1% of total soluble protein. The 
ultrathin sections of leaves expressing scFv-CK showed gold 
particles evenly distributed in the cytosol (Fig. 3A,B), indicat-
ing the presence of scFvs in that compartment. No gold par-
ticles were found in other subcellular compartments. The sec-
Table 1 
Amino acid sequences of the linker peptides present in the various 
scFv antibodies 
Single-chain Linker peptide 
scFv48 
scFv49 
scFv59 
SCFVGUS 
-LEGKSSGSGSESKLES-
-(GGGGS)3-
-G2S-(GGGGS)3-
-REGKSSGSGSESKLES-
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Fig. 3. Localization of scFv-CK and scFv-SK in transgenic tobacco by immunogold labeling and transmission electron microscopy. Leaf sec-
tions from plants expressing scFv-CK at a level of 0.2% (A and B) and scFv-SK at a level of 0.2% (C) and 1% (D) of total soluble protein. E: 
Leaf sections from untransformed plants, chl, chloroplast; cw, cell wall; cy, cytoplasm; rER, rough endoplasmic reticulum; r, ribosome. 
Bars = 1 μpiι. 
tions of the leaves expressing the ER-targeted scFv-SK 
showed gold particles localized in the membranous elements 
coated with electron dense ribosomes, the rough ER (rER) 
(Fig. 3C,D). The number of gold particles correlated with 
the scFv-SK expression level. In several plant cells the struc-
ture of some of the rER was not elongated but vacuolated as 
has been described [35]. No significant labeling was found in 
untransformed leaf sections (Fig. 3E). We therefore conclude 
that, as intended, scFv-SK and scFv-CK were located in the 
ER and the cytosol, respectively. 
linker sequence in a 5'-VL-linker-VH-3' orientation. These 
antibodies were MGR48, MGR49 and MGR59, all reacting 
3.2. Expression of different scFv antibodies in the cytosol of 
tobacco protoplasts 
To determine if the C-terminal KDEL extension could also 
improve cytosolic expression levels of other scFv antibodies 
the variable light (VL) and heavy (VH) domains of four other 
antibodies were amplified by PCR and coupled by a synthetic 
Fig. 4. Western blot analysis of a transient expression assay in to-
bacco protoplasts transformed with the scFv48, scFv59 and scFv49 
constructs without (C) and with (CK) the tetrapeptide KDEL exten-
sion. 
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Fig. 5. Western blot analysis of transgenic potato plants expressing 
scFv48 without (C) and with (-CK) tetrapeptide KDEL extension or 
with tetrapeptide KDEI extension (CI). 
with ß-l,4-endoglucanase, and anti-GUS, reacting with ß-glu-
curonidase. The linker sequences coded for 202' [20] and 
(Gly4Ser)3 peptides or derivatives (Table 1). The scFv sequen-
ces were directly preceded by the ATG translational start 
codon and fused in frame with the c-myc tag coding sequence, 
enabling detection ( 'C constructs). The 'CK' constructs car-
ried the additional KDEL coding sequence at the 3'-end. 
These scFv constructs were transiently expressed in tobacco 
protoplasts. The 21C5 anti-cutinase scFv-C and scFv-CK con-
structs were used as reference. Western blot analysis showed 
that cytosolic expression of the scFv4g and scFv59 constructs 
was improved when the KDEL tetrapeptide was present (Fig. 
4). The estimated expression levels of scFv48-C and scFv48-CK 
were 0.02% and 0.06% of total soluble protein, respectively 
(Fig. 4, lanes 1 and 2). The estimated expression levels of 
SCFV59-C and scFv5g-CK were 0.02% and 0.1% of total soluble 
protein, respectively (Fig. 4, lanes 3 and 4). Poor expression 
was found with SCFV49 for both the C and CK versions. Tran-
sient expression of both SCFVQUS versions gave no detectable 
expression (not shown). Apparently, the KDEL tetrapeptide is 
not capable of improving cytosolic expression of every scFv 
antibody. 
3.3. Cytosolic expression of scFv^g gene cassettes in 
transformed potato 
To determine whether the KDEL extension could improve 
scFv protein expression in the cytosol of another plant species 
we transformed C and CK gene constructs of scFv48 to potato 
by Agrobacterium mediated transformation. Independent ka-
namycin resistant transformante were screened by immuno-
blotting of total protein extracts (Fig. 5). Only 20% of the 
scFv48-C transgenics screened showed expression, at an esti-
mated level of 0.03% of total soluble protein (Fig. 5, lane 1). 
In contrast, 60% of the scFv48-CK transgenics screened 
showed an expression level estimated at 0.15—0.3% of total 
soluble protein (Fig. 5, lane 2). This demonstrates that the 
stabilizing effect of the tetrapeptide in cytosolic expression is 
not restricted to tobacco. 
To study the influence of a modification of the KDEL ex-
tension on protein expression levels, an scFv48-CI gene con-
struct, carrying the KDEI instead of KDEL coding sequence, 
was introduced into potato. This single amino acid substitu-
tion in the tetrapeptide is known to disrupt the retention 
signal and the protein is no longer retained in the ER [13]. 
In 80% of the transgenics screened the scFv48-CI protein ex-
pression level was estimated at 0.3% of total protein (Fig. 5, 
lane 3), indicating that the isoleucine replacement did not 
result in a loss of the stabilizing effect. 
4. Discussion 
The expression of antibodies in plants is a promising ap-
proach for obtaining pathogen resistance or altering metabolic 
pathways. Success depends on proper targeting to the desired 
subcellular compartment combined with proper folding and 
sufficient stability in order to obtain functional antibodies. 
The recent successes [1,3,4] suggest that scFv antibodies, pro-
vided with the proper translocation signals, have these abil-
ities and can even be expressed in the reducing environment of 
the cytosol. However, these scFv antibodies were never prop-
erly localized and cytosolic scFv expression in plants was 
mostly low or absent. We demonstrated previously that the 
expression level of an anti-cutinase scFv antibody targeted to 
the cytosol was significantly enhanced when carrying the 
KDEL sequence C-terminally (scFv-CK) [9]. Stabilizing 
scFv antibodies in the plant cytosol by adding this four amino 
acid sequence, known as the ER retention signal [12], would 
open new possibilities, but the actual subcellular location was 
uncertain. Noteworthy in this respect is that for a cytosolic 
scFv antibody in HeLa cells mistranslocation to the ER was 
suggested [15]. Furthermore, alternative translocation path-
ways to the ER of proteins lacking a signal sequence have 
been described [36-38]. 
In this paper we located unambiguously the scFv-CK in the 
cytosol, excluding possible mistranslocation or alternative 
translocation events to the ER. This was proved using re-
linked glycosylation as a biochemical marker and immuno-
electron microscopy. N-linked glycosylation is a post-transla-
tional modification of proteins and confined to the ER [39]. 
Transient expression assays in tobacco protoplasts of the pos-
itive control, an scFv with ER translocation signal and KDEL 
extension carrying the glycosylation signal (scFvglyc-SK), 
clearly demonstrated that glycosylation occurred, indicating 
that this scFv antibody had been translocated into the ER. 
However, only 70% of the scFvglyc-SK became glycosylated. 
This could have been caused by the fact that the ER trans-
location signal was inefficient, and the scFvglyc-SK was only 
partially translocated into the ER, or that N-linked glycosyl-
ation in the ER was incomplete. The first reason is most 
unlikely since immunoelectron microscopy showed no scFv-
SK outside the ER of the plant cells. Incomplete glycosylation 
in the ER is more likely. Competition between protein folding 
and N-linked glycosylation has been described extensively 
[40-42] and, apart from the X as a determinant in glycosyla-
tion efficiency [43], not all the Asn-X-Ser/Thr sequons in a 
protein become glycosylated [44]. Since the VL domain can 
fold independently into a stable domain [45,46] the nascent 
VL domain may rapidly begin with the formation of the prop-
er domain structure the moment it is translocated into the ER, 
making it difficult for glycosyl transferase to attain the glyco-
sylation signal in the linker pep tide. 
240 
As reported before, the anti-cutinase scFv designed to be 
located in the cytosol could only be detected when the tetra-
peptide KDEL was added C-terminally [9]. We postulated 
that stabilization may have been caused by mistranslocation 
into the ER. In this case, all the scFv-CK antibody present 
would be located in the ER. However, the results showed that 
scFvglyc-CK was not glycosylated, demonstrating that no mis-
translocation into the ER had occurred. The actual subcellu-
lar location was confirmed by immunoelectron microscopy of 
tobacco leaf sections. The scFv-SK was detected in the ER 
and the scFv-CK in the cytosol. No labeling was found in any 
other subcellular compartment. When two plants with similar 
expression levels are analyzed the scFv-CK antibody obvi-
ously becomes more diluted, since the cytosol, compared to 
the ER, is rather large in size. However, the immunodetection 
on the untransformed control plant showed no labeling. It can 
therefore be concluded that the four amino acid extension 
KDEL enhances the anti-cutinase scFv antibody expression 
levels in the cytosol. 
Other scFv antibodies were constructed to investigate a 
broad applicability of the KDEL extension for stabilizing 
scFv antibodies expressed in the cytosol. Expression levels 
were not improved for one anti-ß-l,4-endoglucanase scFv 
(scFv49-CK) and the anti-ß-glucuronidase scFv (SCFVQUS-
CK). However, the other two anti-ß-l,4-endoglucanase scFvs 
(scFv48-CK and scFv59-CK) showed a significantly enhanced 
protein expression level. This was found in both transient 
expression assays and stable transformante. As was already 
demonstrated previously [9] for cytosolic scFvs, the protein 
expression levels in transient expression assays with tobacco 
protoplasts are positively correlated with the levels obtained 
in transformed plants, even if this is a different species. Fur-
thermore, the scFv48-CK protein expression level in the trans-
genic plants, reaching 0.3% of total soluble protein, is very 
similar to what was found for the anti-cutinase scFv-CK [9]. 
How this four amino acid extension is capable of stabilizing 
the scFv antibody still remains elusive. An interaction with 
the transmembrane KDEL receptor is unlikely since the bind-
ing site of the receptor is exclusively located at the lumenal 
side of the ER membrane [47]. In addition, cytosolic scFv 
expression could also be improved when the tetrapeptide 
KDEI was added (scFv48-CI). It was demonstrated before 
that the substitution of leucine into isoleucine disrupted the 
tetrapeptide to act as an ER retention signal [13]. It may 
therefore well be that C-terminal protein degradation is pre-
vented or that the tetrapeptide sterically protects a part of the 
scFv antibody susceptible for proteolysis. 
Although different linker peptides were used to connect the 
variable domains of the different scFvs this seemed not to be 
crucial. The scFv4g, SCFVGUS and the 21C5 scFv-CK [9] and 
scFvAglyc-CK all carried almost identical linker peptides. Yet, 
only the protein expression of the SCFVQUS was not improved 
when the KDEL extension was added. Furthermore, the ex-
pression protein level of scFvsg-CK was considerably im-
proved when compared to scFv5g-C. These scFvs both carried 
the Gly2Ser(Gly4Ser)3 linker. Susceptibility to proteolytic deg-
radation may therefore depend on the amino acid sequence of 
the variable heavy and light domains. Since scFv antibodies 
lack the heavy and light chain constant domains some resi-
dues at the former variable and constant domain interface 
become solvent exposed. Depending on the amino acid se-
quence in this region proper folding and subsequent overall 
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stability may be affected, thus increasing susceptibility to pro-
teolytic degradation. Noteworthy in this respect is the recent 
report in which in COS-1 cells the cytosolic stability of an 
scFv antibody was greatly improved when the entire CK do-
main was added C-terminally [48]. Considering the negative 
results with SCFV49-CK and SCFVQUS-CK, apparently not all 
possible proteolytic sensitive sites are protected by the tetra-
peptide extension. 
As demonstrated with the cytosolic scFv expression in po-
tato, the positive effect of the KDEL extension on the expres-
sion levels does not seem to depend on the choice of the plant 
species. The processes involved in stabilizing scFv antibodies 
in the cytosol of different species may be similar and is there-
fore not a factor determining the success of stable scFv ex-
pression. 
It can be concluded that the tetrapeptide KDEL or KDEI 
can have a beneficial effect on the cytosolic expression levels 
of scFv antibodies in plants. Addition of this four amino acid 
extension may be a simple and effective solution for cytosolic 
scFv antibody expression and therefore is worth trying with 
scFvs which show great promise with respect to their binding 
affinity but cannot be expressed at a sufficient level in the 
plant cytosol. 
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